|
Post by chc on Jun 27, 2019 22:23:48 GMT -5
Kelly Kraft Vice President, Product Development at Receptor Life Sciences Danbury, Connecticut Biotechnology Vice President, Product Development Receptor Life Sciences February 2019 – Present 5 months Image for Director, Pharmaceutical Research Director, Pharmaceutical Research MannKind Corporation June 2003 – February 2019 15 years 9 months Held positions with increasing responsibility, from laboratory scientist to department director. As Director of Pharmaceutical Research, responsibilities include identifying drug candidates and developing strategies for MannKind's inhalation drug delivery pipeline while simultaneously maintaining responsibility for chemical and formulation research on Afrezza (inhaled insulin) and its line extensions for product life cycle management. Other notable responsibilities and accomplishments include: • Establishing and leading a cross-functional team to execute a pipeline program from research stage through a successful first-in-man clinical trial • Building and driving timelines for a US FDA IND submission • Authoring and reviewing sections of regulatory documents for US FDA submissions (IND and NDA) • Establishing, with Quality Assurance, a Phase 1 clinical manufacturing suite • Directing work of up to six formulation, chemistry, and analytical scientists • Developing and optimizing a new manufacturing process to lower novel excipient COGS by 40% • Designing and synthesizing multi-gram quantities of novel delivery agent candidates • Serving on and/or leading cross-disciplinary development program teams
|
|
|
RLS
Jun 28, 2019 15:00:44 GMT -5
chc likes this
Post by ktim on Jun 28, 2019 15:00:44 GMT -5
I don't believe Rubinfeld left Starbucks to start his own branding/marketing consulting firm. Airvision has been around since 2002 when Rubinfeld started it. Prior he was consulting to MSFT on marketing and is how he became friends with Kevin Johnson. www.airvision.com/microsoft Notice Starbucks at the bottom. Rubinfeld was still working at Starbucks for awhile after RLS was announced in 2016. At the time he left Starbucks he was President, Starbucks Coffee - Innovation, Chief Creative Officer and Operational Lead of Starbucks Reserve Roasteries. Why he left when he did we would have to ask him but around the same time is when RLS started to raise money and Rubinfeld is listed on the SEC paperwork. Take at look at this article which says - The SEC filing lists Traci Carman as the president of Receptor. Three other people are listed as directors: patent attorney Gregory Wesner, former high-ranking Starbucks executive Arthur Rubinfeld, who now runs a consumer-focused brand consulting company, and a David Thomson. Its an interesting group. Two from MSFT, two from MNKD. You can call me crazy but IMO the secretive partner not listed is Kevin Johnson who is also from MSFT. Tracking tail number history to DXR is a good place to start. I know if I was about to invest a fortune I would want to see the factory where TS is used. www.geekwire.com/2018/secretive-startup-receptor-life-sciences-raises-7-5m-therapies-based-plant-extracts/Now, I am not trying to be disingenuous but Rubinfeld is up to something and RLS is up to something. Rubinfeld clearly left Starbucks and seems knee deep in RLS. I just hope they start making some announcements real soon. I also hope Rubinfeld is the marketing genius I think he is. It does appear Rubinfeld is involved at the board level. Based on what's been presented by MNKD it appears that the two planned products are ones intended to be FDA approved pharmaceuticals. If that assumption is correct then we should eventually see clinical trials registered.
|
|
|
Post by harryx1 on Jul 17, 2019 13:35:59 GMT -5
|
|
|
RLS
Jul 17, 2019 13:54:10 GMT -5
Post by rtmd on Jul 17, 2019 13:54:10 GMT -5
Don't see any mention of RLS though. Just looks like a lot of competition. Three of them are already marketing devices.
|
|
|
RLS
Jul 20, 2019 8:33:47 GMT -5
rtmd likes this
Post by winner on Jul 20, 2019 8:33:47 GMT -5
MNKD Executive Team Consider asking and updating shareholders as to when RLS plan on launching their MNKD product. If their answer is unacceptable, can MNKD offer the compound to others, who commit to making this product available sooner.
|
|
|
RLS
Jul 26, 2019 12:48:25 GMT -5
via mobile
Post by longliner on Jul 26, 2019 12:48:25 GMT -5
For a pick me up read the RLS website.
|
|
|
Post by peppy on Jul 26, 2019 12:57:16 GMT -5
For a pick me up read the RLS website. www.receptorlife.com/technologyOur exclusive, patented technologies incorporate years of drug-development research and are validated through their use in FDA-approved products. These technologies will make us the first cannabinoid-focused biopharmaceutical company to offer consistent dosing, high bioavailability and predictable, consistent and rapid absorption with every treatment. By applying our portfolio of drug delivery technologies to cannabinoids, we will harness and enhance the potential of cannabinoids to address unmet medical needs, redefining how patients benefit from this important class of therapeutics. www.receptorlife.comReceptor Life Sciences is a biopharmaceutical company developing oral and inhaled cannabinoid medicines characterized by rapid absorption, high bioavailability and consistent dosing. Receptor’s pharmaceutical drug delivery technologies are validated by their use in FDA-approved products. Receptor’s oral products are designed to enhance drug absorption from the GI tract, leading to improved bioavailability and reduced variability compared to existing oral cannabinoid products. Receptor’s inhaled products combine a simple-to-use, breath-powered inhaler with dry powder formulations of cannabinoids, providing ultra-rapid, consistent and discreet delivery of cannabinoid medicines to the deep lung. The company’s product candidates are currently in a preclinical stage of development. Check back regularly for updates to our pipeline priorities.
|
|
|
RLS
Jul 26, 2019 13:13:21 GMT -5
Post by mnkdfann on Jul 26, 2019 13:13:21 GMT -5
For a pick me up read the RLS website. I noticed just the other day how gender diverse the Advisory Board was ... then I realised the Board photo was a stock image, and the Board is actually solely men. www.receptorlife.com/scientific-advisory-board
|
|
|
Post by longliner on Jul 26, 2019 13:13:54 GMT -5
It wasn't long ago it was just a tree!
|
|
|
Post by sportsrancho on Jul 26, 2019 16:12:51 GMT -5
It wasn't long ago it was just a tree! Lol👍🏻👌
|
|
|
Post by shake34 on Aug 2, 2019 19:57:46 GMT -5
Kevinmik on stocktwits said aphria had a great earning report and sp went up 40 percent. No doubt cannabis is the new hot fad or maybe the next new do it all drug. I see it advertised all over facebook. I sure feel like rls is missing out on a lot of easy money right now. Does anybody know what they are waiting for? How much longer before they can bring something to the market?
|
|
|
Post by letitride on Aug 2, 2019 20:02:27 GMT -5
If their working in Canada it should have been yesterday.
|
|
|
Post by sayhey24 on Aug 3, 2019 6:53:51 GMT -5
Kevinmik on stocktwits said aphria had a great earning report and sp went up 40 percent. No doubt cannabis is the new hot fad or maybe the next new do it all drug. I see it advertised all over facebook. I sure feel like rls is missing out on a lot of easy money right now. Does anybody know what they are waiting for? How much longer before they can bring something to the market? "Does anybody know what they are waiting for?" I think Mike C. knows. I will say they have done a great job of keeping things secret. Everyday I check for the big press release and everyday it does not come. One day it will and I think sooner than later.
|
|
|
RLS
Aug 3, 2019 9:58:37 GMT -5
via mobile
Post by sellhighdrinklow on Aug 3, 2019 9:58:37 GMT -5
Please correct me if wrong, but the maximum in royalties that mnkd can from rls is 100 million.
|
|
|
RLS
Aug 3, 2019 10:29:16 GMT -5
via mobile
Post by uvula on Aug 3, 2019 10:29:16 GMT -5
Please correct me if wrong, but the maximum in royalties that mnkd can from rls is 100 million. We already got 1M so maybe we are now limited to only 99M.
|
|